Need Help? Call 1­-866-­796-­7386
« back to stock screener

  MYGN stock: Myriad Genetics, Inc.

Current Rating
Hold/Sell

Previous Rating:

Strong Sell
Our Stock Ratings
double the S&P500!
Learn more.
Company Statistics
Price
$19.15
Market Cap
1.32B
Sector
Health Care
Div. Growth
-
P/E
19.1
P/B
1.77
P/S
1.73
Dividend %
-
P/CF
-
P/FCF
34.0
Op. Cash Flow
47.1K
FCF
0.5
Op. Margin
13.00%
Net Margin
9.70%
ROE
9.80%
ROI
16.50%
ROA
6.80%
EPS Growth
-32.50%
Current Ratio
4.3
Debt/Equity
-
Company Price P/E Div. Yield Market Cap ($Mil) Rating
Lannett Company, Inc. (LCI) $21.20 - - 812.6M Strong Buy
Nephros, Inc. (NEPH) $0.38 - - 19.7M Strong Buy
Community Health Systems (CYH) $8.70 - - 1.05B Strong Buy
Bioanalytical Systems, Inc. (BASI) $1.33 - - 13.4M Strong Buy
Oramed Pharmaceuticals, Inc. (ORMP) $5.93 - - 81.3M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More